The abstract is read at the publisher; the summary is JClub's.
In a 10-year type 2 diabetes cohort, 27% of eyes worsened and 21% improved, and OCTA-identified microvascular nonperfusion distinguished worsening/stable eyes from improving eyes.
- Why it matters: Diabetic retinopathy progression varies over time, and clinicians need noninvasive markers to flag eyes likely to progress toward vision loss.
- What they did: Among 115 participants who reached the 10-year visit (from 222 enrolled), investigators used noninvasive OCTA to measure microvascular nonperfusion and compared OCTA patterns across Early Treatment Diabetic Retinopathy Study severity outcomes.
- The result: OCTA-based detection of microvascular nonperfusion progression is linked to higher risk of disease progression, enabling identification of patients more likely to worsen.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.